Maggie Harman
Family · New Bern, NCNPI 1730854712
Payments from drug & device makers
Across 49 payments — averaging $19.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$260
- TG Therapeutics, Inc.$107
- Neurelis, Inc.$96
- Neurocrine Biosciences, Inc.$40
- CSL Behring$39
- Acadia Pharmaceuticals Inc$35
- plus $361 from 17 others
What the payments were for
- Food & beverage$937100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 14 | $260 |
| TG Therapeutics, Inc. | 4 | $107 |
| Neurelis, Inc. | 6 | $96 |
| Neurocrine Biosciences, Inc. | 2 | $40 |
| CSL Behring | 2 | $39 |
| Acadia Pharmaceuticals Inc | 2 | $35 |
| AbbVie | 2 | $32 |
| Eisai Inc. | 2 | $31 |
| UCB, Inc. | 1 | $31 |
| Amgen | 1 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $26 |
| AstraZeneca | 1 | $25 |
| Scilex Pharmaceuticals Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
| Pfizer | 1 | $19 |
| EMD Serono, Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $18 |
| Merz Pharmaceuticals, LLC | 1 | $18 |
| Insightec,inc | 1 | $16 |
| Johnson & Johnson | 1 | $14 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| Medtronic | 1 | $14 |
| The Binding Site Inc. | 1 | $11 |
How this compares
$937 in reported general payments places this provider in the 65th percentile of 4,522 family providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mirtazapine | 18 | $195 |
| Donepezil Hcl | 33 | $164 |
| Memantine Hcl | 11 | $121 |
| Lorazepam | 13 | $118 |
| Sertraline Hcl | 17 | $45 |
Paid to pharmacies, not to this prescriber.
Other family in New Bern
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
- Teresa DossWilmington$137K
- Debra ScottCharlotte$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.